威尔药业
(603351)
| 流通市值：34.73亿 | | | 总市值：34.73亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,000,364,429.23 | 688,157,870.31 | 329,832,361.62 | 1,155,839,777.59 |
| 营业收入 | 1,000,364,429.23 | 688,157,870.31 | 329,832,361.62 | 1,155,839,777.59 |
| 二、营业总成本 | 886,687,537.69 | 606,291,744.8 | 290,059,404.32 | 1,037,710,321.21 |
| 营业成本 | 741,019,493.32 | 509,259,176.74 | 243,995,162.64 | 839,036,256.46 |
| 税金及附加 | 6,702,957.05 | 4,396,367.44 | 2,229,232.8 | 7,321,324.98 |
| 销售费用 | 10,424,902.41 | 6,788,097.2 | 2,882,667.77 | 12,835,240.56 |
| 管理费用 | 71,277,490.08 | 47,400,775.59 | 22,793,522.43 | 108,665,944.46 |
| 研发费用 | 47,691,176.39 | 31,831,986.94 | 15,768,635.95 | 55,644,643.28 |
| 财务费用 | 9,571,518.44 | 6,615,340.89 | 2,390,182.73 | 14,206,911.47 |
| 其中:利息费用 | 10,548,555.71 | 7,615,042.57 | 3,184,113.95 | 14,174,206.99 |
| 其中:利息收入 | 746,897.77 | 428,681.34 | 207,013.92 | 783,310.41 |
| 加:公允价值变动收益 | 12,072,961.13 | 12,072,961.13 | -47,700 | 1,439,968.42 |
| 加:投资收益 | -68,940 | -68,940 | - | 100.03 |
| 资产减值损失(新) | -3,847,764.11 | -3,847,764.11 | - | -3,934,256.3 |
| 信用减值损失(新) | -83,519.23 | -622,881.1 | -218,985.33 | -51,927.94 |
| 其他收益 | 7,148,520.41 | 5,305,081.05 | 1,334,761.46 | 6,193,186.73 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 128,898,149.74 | 94,704,582.48 | 40,841,033.43 | 121,776,527.32 |
| 加:营业外收入 | - | - | - | 18,868.97 |
| 减:营业外支出 | 167,145.27 | 72,842.95 | 11,681.45 | 354,160.78 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 128,731,004.47 | 94,631,739.53 | 40,829,351.98 | 121,441,235.51 |
| 减:所得税费用 | 17,699,818.17 | 16,918,489.14 | 7,312,919.77 | 12,326,673.3 |
| 六、净利润 | 111,031,186.3 | 77,713,250.39 | 33,516,432.21 | 109,114,562.21 |
| 持续经营净利润 | 111,031,186.3 | 77,713,250.39 | 33,516,432.21 | 109,114,562.21 |
| 归属于母公司股东的净利润 | 112,897,296.64 | 78,895,240.65 | 34,603,545.42 | 112,199,192.87 |
| 少数股东损益 | -1,866,110.34 | -1,181,990.26 | -1,087,113.21 | -3,084,630.66 |
| (一)基本每股收益 | 0.83 | 0.58 | 0.26 | 0.83 |
| (二)稀释每股收益 | 0.83 | 0.58 | 0.26 | 0.83 |
| 九、综合收益总额 | 111,031,186.3 | 77,713,250.39 | 33,516,432.21 | 109,114,562.21 |
| 归属于母公司股东的综合收益总额 | 112,897,296.64 | 78,895,240.65 | 34,603,545.42 | 112,199,192.87 |
| 归属于少数股东的综合收益总额 | -1,866,110.34 | -1,181,990.26 | -1,087,113.21 | -3,084,630.66 |
| 公告日期 | 2024-10-24 | 2024-08-20 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |